echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAHA: Risks and benefits of early rhythm control in patients with acute stroke and atrial fibrillation

    JAHA: Risks and benefits of early rhythm control in patients with acute stroke and atrial fibrillation

    • Last Update: 2022-02-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The purpose of the Risks and Benefits of Emergency Rhythm Control in Atrial Fibrillation in Patients with Acute Stroke (RAFAS) trial was to investigate the risks and benefits of early rhythm control in newly documented patients with atrial fibrillation (AF) during acute ischemic stroke


    stroke

    Recently , a research article was published in JAHA, an authoritative journal in the field of cardiovascular disease.


    Vascular diagnosis

    The primary endpoint of the study was recurrent acute ischemic stroke within 3 and 12 months


    Arrhythmia

    Patients (n=300) with AF and acute ischemic stroke (63.


    CONCLUSIONS: Early rhythm control strategies in patients with acute ischemic stroke reduced persistent AF and recurrent stroke at 12 months without an increase in composite adverse outcomes


    Early rhythm control strategies in patients with acute ischemic stroke reduced persistent AF and recurrent stroke at 12 months without an increase in composite adverse outcomes


    Original source:

    Junbeom Park.


    Risks and Benefits of Early Rhythm Control in Patients With Acute Strokes and Atrial Fibrillation: A Multicenter, Prospective, Randomized Study (the RAFAS Trial)

    Leave a Comment
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.